195 related articles for article (PubMed ID: 21952811)
1. Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.
Stoitzner P; Romani N
Eur J Immunol; 2011 Sep; 41(9):2526-9. PubMed ID: 21952811
[TBL] [Abstract][Full Text] [Related]
2. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
[TBL] [Abstract][Full Text] [Related]
3. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
[TBL] [Abstract][Full Text] [Related]
4. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
5. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
Flacher V; Sparber F; Tripp CH; Romani N; Stoitzner P
Cancer Immunol Immunother; 2009 Jul; 58(7):1137-47. PubMed ID: 18677477
[TBL] [Abstract][Full Text] [Related]
6. Langerin functions as an antiviral receptor on Langerhans cells.
van der Vlist M; Geijtenbeek TB
Immunol Cell Biol; 2010; 88(4):410-5. PubMed ID: 20309013
[TBL] [Abstract][Full Text] [Related]
7. C-type lectin Langerin is a beta-glucan receptor on human Langerhans cells that recognizes opportunistic and pathogenic fungi.
de Jong MA; Vriend LE; Theelen B; Taylor ME; Fluitsma D; Boekhout T; Geijtenbeek TB
Mol Immunol; 2010 Mar; 47(6):1216-25. PubMed ID: 20097424
[TBL] [Abstract][Full Text] [Related]
8. Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.
Fehres CM; Duinkerken S; Bruijns SC; Kalay H; van Vliet SJ; Ambrosini M; de Gruijl TD; Unger WW; Garcia-Vallejo JJ; van Kooyk Y
Cell Mol Immunol; 2017 Apr; 14(4):360-370. PubMed ID: 26456691
[TBL] [Abstract][Full Text] [Related]
9. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
[TBL] [Abstract][Full Text] [Related]
10. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
11. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.
Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N
EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878
[TBL] [Abstract][Full Text] [Related]
12. Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells.
Hunger RE; Sieling PA; Ochoa MT; Sugaya M; Burdick AE; Rea TH; Brennan PJ; Belisle JT; Blauvelt A; Porcelli SA; Modlin RL
J Clin Invest; 2004 Mar; 113(5):701-8. PubMed ID: 14991068
[TBL] [Abstract][Full Text] [Related]
13. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
[TBL] [Abstract][Full Text] [Related]
14. Host Langerin (CD207) is a receptor for Yersinia pestis phagocytosis and promotes dissemination.
Yang K; Park CG; Cheong C; Bulgheresi S; Zhang S; Zhang P; He Y; Jiang L; Huang H; Ding H; Wu Y; Wang S; Zhang L; Li A; Xia L; Bartra SS; Plano GV; Skurnik M; Klena JD; Chen T
Immunol Cell Biol; 2015 Oct; 93(9):815-24. PubMed ID: 25829141
[TBL] [Abstract][Full Text] [Related]
15. The dermis contains langerin+ dendritic cells that develop and function independently of epidermal Langerhans cells.
Poulin LF; Henri S; de Bovis B; Devilard E; Kissenpfennig A; Malissen B
J Exp Med; 2007 Dec; 204(13):3119-31. PubMed ID: 18086861
[TBL] [Abstract][Full Text] [Related]
16. Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function.
Kissenpfennig A; Aït-Yahia S; Clair-Moninot V; Stössel H; Badell E; Bordat Y; Pooley JL; Lang T; Prina E; Coste I; Gresser O; Renno T; Winter N; Milon G; Shortman K; Romani N; Lebecque S; Malissen B; Saeland S; Douillard P
Mol Cell Biol; 2005 Jan; 25(1):88-99. PubMed ID: 15601833
[TBL] [Abstract][Full Text] [Related]
17. Langerin/CD207 sheds light on formation of birbeck granules and their possible function in Langerhans cells.
Valladeau J; Dezutter-Dambuyant C; Saeland S
Immunol Res; 2003; 28(2):93-107. PubMed ID: 14610287
[TBL] [Abstract][Full Text] [Related]
18. Langerin+ dermal DC, but not Langerhans cells, are required for effective CD8-mediated immune responses after skin scarification with vaccinia virus.
Seneschal J; Jiang X; Kupper TS
J Invest Dermatol; 2014 Mar; 134(3):686-694. PubMed ID: 24126845
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Langerhans cells rapidly capture and present antigens from C-type lectin-targeting antibodies deposited in the dermis.
Flacher V; Tripp CH; Stoitzner P; Haid B; Ebner S; Del Frari B; Koch F; Park CG; Steinman RM; Idoyaga J; Romani N
J Invest Dermatol; 2010 Mar; 130(3):755-62. PubMed ID: 19890348
[TBL] [Abstract][Full Text] [Related]
20. Human Herpesvirus 8 Infects and Replicates in Langerhans Cells and Interstitial Dermal Dendritic Cells and Impairs Their Function.
Rappocciolo G; Jais M; Piazza PA; DeLucia DC; Jenkins FJ; Rinaldo CR
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
